0000896262-22-000011.txt : 20220222 0000896262-22-000011.hdr.sgml : 20220222 20220222210040 ACCESSION NUMBER: 0000896262-22-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220217 FILED AS OF DATE: 20220222 DATE AS OF CHANGE: 20220222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kusserow Paul B. K. CENTRAL INDEX KEY: 0001456688 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 22660390 MAIL ADDRESS: STREET 1: 780 SAN YSIDRO ROAD CITY: SANTA BARBARA STATE: CA ZIP: 93108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 wf-form4_164558162362374.xml FORM 4 X0306 4 2022-02-17 0 0000896262 AMEDISYS INC AMED 0001456688 Kusserow Paul B. K. 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 1 1 0 0 See Remarks Common Stock 2022-02-17 4 M 0 49092 0 A 398663 D Common Stock 2022-02-17 4 F 0 9659 143.25 D 389004 D Common Stock 2022-02-17 4 F 0 9659 143.25 D 379345 D Common Stock 83764 I By Trust Common Stock 621 I Through 401(k) Plan Restricted Stock Units 2022-02-17 4 M 0 73638 0 D Common Stock 73638.0 0 D On January 2, 2019, the Reporting Person was awarded 73,638 performance-based Restricted Stock Units ("RSUs") with vesting based on certification of achievement of identified performance goals for each of fiscal years 2019 through 2021 (1/3 of the RSUs vest, if at all, based on achievement of the 2019 performance goal; 1/3 of the RSUs vest, if at all, based on achievement of the 2020 performance goal; and 1/3 of the RSUs vest, if at all, based on achievement of the 2021 performance goal). The Compensation Committee of the Issuer has certified achievement of the 2019 and 2020 performance measures, but the 2021 performance measure was not satisfied, thereby resulting in the Reporting Person earning 49,092 shares of common stock, which are reported in Table I. The information in this report is based on a plan statement dated as of December 31, 2021. CEO and Chairman of the Board /s/ Jennifer R. Guckert, pursuant to a power of attorney 2022-02-22